ASHP Midyear Virtual Experience

A 503B Pharmaceutical Outsourcing Solution You Can Rely On

As a leader in 503B Outsourcing, Fagron Sterile Services US (FSS) continues to support our customers and the safety of the patients they serve by engaging in industry leading conferences, trade shows and events.

This year ASHP decided to hold a virtual event to support health and safety during the pandemic, while still providing an important opportunity for pharmacists and suppliers to network.

The conference is also a strong advocate of continuing education and all participants will have a variety of opportunities to present and review scholarly research, take educational courses for CE credit and hear from industry experts.

ASHP Midyear 2020 includes a number of guest speakers including this year's keynotes with Tom Hanks and Dr. Anthony Fauci.

We look forwarding to seeing and speaking with you, better yet, schedule a virtual or in-person (COVID restrictions/precautions apply) facility visit and see why pharmacists trust FSS to deliver a 503B solution you can rely on.

Live Webinar Session with Q&A

Wednesday, December 9th, 2:00 PM (CST) | Duration: 30 Minutes

Learn more about 503B Outsourcing and the latest product innovations from FSS! Introducing the first Sterile Topical LET Gel, a revolutionary silicone-free Avastin presentation, and the continued expansion of OR anesthesia offerings in IV Bags and ready-to-administer syringes.

FSS Director of Marketing, Sean Jones, hosts a conversation and Q&A with Glen Olsheim, FSS VP of Business & New Product Development and Jason McGuire, Global Quality Director for Fagron.

About Fagron Sterile Services US

Fagron Sterile Services US (FSS), a top-tier DEA and FDA-Registered 503B Outsourcing Provider, produces a reliable supply of high-quality sterile medications with cGMP compliant operations for patient-focused healthcare facilities across North America.

FSS' team employs expertise in legal and regulatory compliance, pharmaceutical manufacturing and repackaging, leveraging industry leading automation, advanced environmental monitoring and sophisticated in-house quality testing labs. Batches are validated to support Beyond Use Dating (BUD) and only released after successful sterility, particulate matter and potency testing are complete.

FSS offers a broad product portfolio across Operating Room Anesthesia (OR Syringes & IV Bags), Ophthalmics, Pain Management, and other Specialty Presentations, while holding Integrated Delivery Network (IDN)agreements within all major GPOs.

Follow FSS on LinkedIn and Twitter and sign up for our newsletter to receive the latest updates.

‍

Learn more today, fill out a free consultation request at fagronsterile.com.

‍

‍